Orphan Drugs and High-Cost Medications Are Concentrating Self-Funded Pharmacy Spend Into a Handful of Members
More than half of new FDA approvals are rare disease drugs with 7-figure costs. Most employers have never priced one, and renewal is the only window. CO, UNITED STATES, August 18, 2026 /EINPresswire.com/ -- Limitless Consulting released an …